Extendicare Inc. (OTCMKTS:EXETF – Get Free Report) rose 0.1% during mid-day trading on Monday . The company traded as high as $22.1193 and last traded at $22.1193. Approximately 668,325 shares were traded during trading, an increase of 1,021% from the average daily volume of 59,636 shares. The stock had previously closed at $22.09.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the stock. TD Securities reissued a “buy” rating on shares of Extendicare in a report on Monday, May 11th. Canadian Imperial Bank of Commerce restated an “outperform” rating on shares of Extendicare in a report on Monday, August 10th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Extendicare in a research report on Friday, August 14th. Five analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has an average rating of “Buy”.
Read Our Latest Stock Analysis on Extendicare
Extendicare Trading Up 0.1%
Extendicare Company Profile
Extendicare Inc (OTCMKTS:EXETF) is a Canada-based senior care provider headquartered in Markham, Ontario. The company specializes in the ownership and operation of long-term care homes, retirement residences and home health care services. It is publicly listed on the Toronto Stock Exchange under the symbol EXE and trades in the over-the-counter market as EXETF.
Extendicare’s operations are organized into two primary segments. The Long-Term Care & Retirement Living division operates approximately 120 facilities under the Extendicare and EspritVitalité banners, serving residents in Ontario, Alberta, Saskatchewan and parts of Atlantic Canada.
See Also
- Five stocks we like better than Extendicare
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
